全文获取类型
收费全文 | 949篇 |
免费 | 30篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 41篇 |
妇产科学 | 47篇 |
基础医学 | 69篇 |
口腔科学 | 16篇 |
临床医学 | 57篇 |
内科学 | 327篇 |
皮肤病学 | 24篇 |
神经病学 | 50篇 |
特种医学 | 19篇 |
外科学 | 127篇 |
综合类 | 29篇 |
预防医学 | 83篇 |
眼科学 | 37篇 |
药学 | 24篇 |
肿瘤学 | 22篇 |
出版年
2024年 | 1篇 |
2023年 | 4篇 |
2022年 | 24篇 |
2021年 | 15篇 |
2020年 | 9篇 |
2019年 | 7篇 |
2018年 | 22篇 |
2017年 | 23篇 |
2016年 | 18篇 |
2015年 | 38篇 |
2014年 | 46篇 |
2013年 | 83篇 |
2012年 | 124篇 |
2011年 | 153篇 |
2010年 | 98篇 |
2009年 | 29篇 |
2008年 | 42篇 |
2007年 | 48篇 |
2006年 | 64篇 |
2005年 | 47篇 |
2004年 | 19篇 |
2003年 | 17篇 |
2002年 | 41篇 |
2001年 | 7篇 |
2000年 | 3篇 |
1991年 | 1篇 |
排序方式: 共有983条查询结果,搜索用时 189 毫秒
1.
2.
3.
Viroj Wiwanitkit 《Clinical and applied thrombosis/hemostasis》2006,12(1):93-95
Platelet glycoprotein (GP) IIb/IIIa is a membrane receptor for fibrinogen and von Willebrand factor. There is considerable controversy regarding the clinical role of the GPIIb/IIIa PIA1/A2 as a risk factor for myocardial infarction. A summative analysis is performed on the recent previous reports on the GPIIb/IIIa PIA1/A2 and its correlation to myocardial infarction. The metanalysis was performed to assess the correlation between the pattern of GPIIb/IIIa PIA1/A2 polymorphism and myocardial infarction. From 7 available case-control reports, 553 patients and 1,059 controls are evaluated. The overall frequencies of PIA2 allele for the patients and controls are 0.249 and 0.221, respectively. According to this study, 49.4% of subjects with PIA2 allele have myocardial infarction while 39.5% of subjects without PIA2 allele have cerebrovascular disease. From overall risk estimation, the subjects with PIA2 alleles have a 1.1 times higher risk to have myocardial infarction. According to this analysis, it is proposed that the pattern of GPIIb/IIIa PIA1/A2 polymorphism does not represent a useful marker of increased risk for myocardial infarction. In addition, the lack of association between the pattern of GPIIb/IIIa PIA1/A2 polymorphism and ethnicity of the patients was demonstrated in this study. 相似文献
4.
Viroj Wiwanitkit 《Sexuality and disability》2005,23(1):41-46
The incidence of sexual assault continues to escalate, and it is under-reported. Recent literature discusses the medical, legal, and psychological management of the female sexual assault victim, but little has been written regarding appropriate management of male sexual assault. This article focuses on the laboratory investigation in male rape case. 相似文献
5.
Can adiponectin predict gestational diabetes? 总被引:5,自引:0,他引:5
Sawaek Weerakiet Kanyarat Lertnarkorn Panyu Panburana Somsri Pitakitronakorn Kanokwan Vesathada Surapee Wansumrith 《Gynecological endocrinology》2006,22(7):362-368
The aim of the present study was to evaluate whether adiponectin is a predictive factor for gestational diabetes mellitus (GDM) and is appropriate as a screening test for GDM. Three-hundred and fifty-nine women with singleton pregnancy and indications for GDM screening according to criteria of the American College of Obstetricians and Gynecologists were enrolled in the study between July 5, 2004 and March 11, 2005. After confirming gestational age (GA) and number of fetuses by ultrasound, all women underwent a 1-h glucose challenge test with 50 g glucose load (50-g GCT) between 21 and 27 weeks of GA. Blood samples for determination of adiponectin levels were also obtained on the same day. Subsequently, between 24 and 28 weeks of GA, the women underwent an oral glucose tolerance test with 100 g glucose load (100-g OGTT). The diagnosis of GDM was established when two or more of the following criteria were fulfilled: (1) fasting glucose >95 mg/dl; (2) 1-h glucose >180 mg/dl; (3) 2-h glucose >155 mg/dl; (4) 3-h glucose >140 mg/dl. Sixty women were diagnosed with GDM, a prevalence of 16.7%. There was no difference in age between the GDM and non-GDM groups. Pre-pregnancy and sampling-day body mass index (BMI), increase in weight and all blood glucose levels were greater in women with GDM than in those without (p < 0.05). Adiponectin concentrations were significantly negatively correlated with GA and plasma glucose levels of the GCT and each OGTT. Using logistic regression analyses, adiponectin, but not age, pre-pregnancy BMI and increase in weight, was demonstrated as an independent predictive factor for GDM. The area under the receiver-operator characteristic curve of adiponectin was significantly lower than that of the GCT [0.63 (95% confidence interval (CI) 0.53-0.67) vs. 0.73 (95% CI 0.71-0.80), p < 0.001]. At a cut-off value of 140 mg/dl of the 50-g GCT, the sensitivity and specificity of the test were 90% and 61%, respectively. The 50-g GCT could identify GDM in 54 (90%) out of 60 women. On the other hand, at an arbitrary cut-off value of 10 microg/ml for adiponectin, sensitivity of 91% and specificity of 31% were achieved. If this cut-off value was used for ruling in or out pregnant women for the GDM screening, 27% of all women could be eliminated from needing to perform an OGTT, with five women (8.3%) misclassified. In conclusion, this study demonstrated that adiponectin was an independent predictor for GDM. As for GDM screening, adiponectin was not as strong a predictor as GCT. However, with advantage of being less cumbersome, adiponectin could be used to rule out pregnant women at low risk of GDM. 相似文献
6.
7.
8.
9.
10.